Anticoagulation in atrial fibrillation. A large real-world update-Reference-Cited by-同舟云学术

Anticoagulation in atrial fibrillation. A large real-world update

Published:2023-10 Issue: Volume: Page:
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Bo Mario^ORCID,Fumagalli Stefano^ORCID,Degli Esposti Luca,Perrone Valentina,Dovizio Melania,Poli Daniela,Marcucci Rossella,Verdecchia Paolo^ORCID,Reboldi Gianpaolo^ORCID,Lip Gregory Y.H.^ORCID,Ungar Andrea,Boccanelli Alessandro,Fumagalli Carlo,Marchionni Niccolò

Publisher

Elsevier BV

Subject

Internal Medicine

Reference31 articles.

1. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex;Carnicelli;Circulation,2022

2. Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study;Larsen;BMJ,2016

3. Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients;Lip;Stroke,2018

4. Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care;Vinogradova;BMJ,2018

5. Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study;Rutherford;Eur Heart J Cardiovasc Pharmacother,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry;European Journal of Internal Medicine;2024-07

2. Atrial Thrombosis Prevalence Before Cardioversion or Catheter Ablation of Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists;The American Journal of Cardiology;2024-05

3. Oral anticoagulation for atrial fibrillation and high risk of bleeding in daily practice: What clinical considerations?;Kardiologia Polska;2024-01-31

4. Rethinking the use of direct oral anticoagulants for secondary thromboprophylaxis in patients with thrombotic antiphospholipid syndrome;Drug Discoveries & Therapeutics;2024